John Chevalier - Procter Gamble Director - Investor Relations
| PG Stock | MXN 3,683 26.69 0.72% |
Director
John Chevalier is Director - Investor Relations of Procter Gamble DRC
| Phone | 513 983 1100 |
| Web | https://www.pginvestor.com |
Procter Gamble Management Efficiency
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3202 %, meaning that it generated $0.3202 on every $100 dollars invested by stockholders. Procter Gamble's management efficiency ratios could be used to measure how well Procter Gamble manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Sandra Macquillan | Kimberly Clark de Mxico | 52 | |
| Fernando Velasco | Kimberly Clark de Mxico | N/A | |
| Alejandro Curbelo | Kimberly Clark de Mxico | N/A | |
| Ernesto Diaz | Kimberly Clark de Mxico | N/A | |
| Antonio Arino | Kimberly Clark de Mxico | 84 | |
| Michael Hsu | Kimberly Clark de Mxico | 54 | |
| Maria Henry | Kimberly Clark de Mxico | 53 | |
| Emilio Gamboa | Kimberly Clark de Mxico | 81 | |
| Jorge Franco | Kimberly Clark de Mxico | 69 | |
| Fernando Mestre | Kimberly Clark de Mxico | 69 | |
| Luiz Rodrigues | Kimberly Clark de Mxico | N/A | |
| Graeme Pitkethly | Unilever PLC | 56 | |
| Carlos Curiel | Kimberly Clark de Mxico | N/A | |
| Juan Urevig | Kimberly Clark de Mxico | N/A | |
| Jesus Laporte | Kimberly Clark de Mxico | 52 | |
| Jorge Rojas | Kimberly Clark de Mxico | N/A | |
| Virgilio Cantillo | Kimberly Clark de Mxico | N/A | |
| Roberto Palacios | Kimberly Clark de Mxico | N/A | |
| Esteban Fomperosa | Kimberly Clark de Mxico | 70 | |
Management Performance
| Return On Equity | 0.32 | |||
| Return On Asset | 0.0955 |
Procter Gamble DRC Leadership Team
Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kathleen Fish, Chief Research, Development and Innovation Officer | ||
| Craig Buchholz, Chief Communications Officer and Vice President – Communications, Personal Health Care and Oral Care | ||
| Matthew Janzaruk, VP Officer | ||
| Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures | ||
| Debra Lee, Independent Director | ||
| Mindy Sherwood, President Global Walmart | ||
| Amy Chang, Independent Director | ||
| Nelson Peltz, Independent Director | ||
| Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations | ||
| Kirti Singh, Chief Analytics and Insights Officer | ||
| Francis Blake, Independent Director | ||
| Thomas Finn, President - Personal Health Care | ||
| Alexandra Keith, President - Global Hair Care and Beauty Sector | ||
| Valarie Sheppard, Controller and Treasurer and Executive Vice President - Company Transition Leader | ||
| Fama Francisco, Chief Executive Officer - Baby and Feminine Care | ||
| Loic Tassel, President - Europe | ||
| Margaret Whitman, Independent Director | ||
| Walter McNerney, Lead Independent Director | ||
| Terry Lundgren, Independent Director | ||
| Shelly McNamara, Senior Vice President of Human Resources | ||
| Angela Braly, Independent Director | ||
| M Grabowski, Chief Human Resource Officer | ||
| Javier Polit, Chief Information Officer | ||
| B Allen, Independent Director | ||
| Steven Bishop, Chief Executive Officer - Health Care | ||
| Scott Cook, Independent Director | ||
| Henry Karamanoukian, President Go-to-Market, China and Hair Care, Greater China | ||
| Sundar Raman, President - Fabric Care, North America and P&G Professional, Global | ||
| Susan Whaley, Chief Sec | ||
| R Keith, Chief Executive Officer - Beauty | ||
| Jennifer Davis, President - Feminine Care | ||
| John Chevalier, Director - Investor Relations | ||
| Juan Posada, President - Latin America Selling and Market Operations | ||
| Fatima Francisco, Feminine Baby | ||
| Monica Turner, Senior Vice President - Sales, North America | ||
| Vittorio Cretella, Chief Information Officer | ||
| Christine McCarthy, Independent Director | ||
| Patricia Woertz, Independent Director | ||
| Shailesh Jejurikar, Chief Executive Officer - Fabric and Home Care | ||
| Philip Duncan, Chief Design Officer | ||
| Andre Schulten, Chief Officer | ||
| Marc Pritchard, Global Brand Building Officer | ||
| Markus Strobel, President - Skin & Personal Care | ||
| David Taylor, Chairman of the Board, President, Chief Executive Officer | ||
| Joseph Jimenez, Independent Director | ||
| Matthew Price, President - Greater China Selling and Market Operations | ||
| Julio Nemeth, President - Global Business Services | ||
| Laura Becker, President - Global Business Services | ||
| Deborah Majoras, Chief Legal Officer, Secretary | ||
| Jon Moeller, Vice Chairman of the Board, Chief Financial Officer | ||
| Gary Coombe, President - Europe Selling and Market Operations | ||
| Carolyn Tastad, Group President - North America and Chief Sales Officer | ||
| Ken Patel, Chief Counsel |
Procter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.32 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 7.61 T | |||
| Shares Outstanding | 2.36 B | |||
| Shares Owned By Insiders | 0.12 % | |||
| Shares Owned By Institutions | 65.88 % | |||
| Price To Earning | 25.58 X | |||
| Price To Book | 8.32 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Procter Stock Analysis
When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.